Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort

Published:2017-12-18 Issue:4 Volume:47 Page:485-493
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Tadbiri S.¹,Peyrin-Biroulet L.²^ORCID,Serrero M.³,Filippi J.⁴,Pariente B.⁵^ORCID,Roblin X.⁶^ORCID,Buisson A.⁷^ORCID,Stefanescu C.⁸,Trang-Poisson C.⁹,Altwegg R.¹⁰,Marteau P.¹¹,Vaysse T.¹²,Bourrier A.¹³,Nancey S.¹⁴,Laharie D.¹⁵,Allez M.¹⁶,Savoye G.¹⁷,Gilletta C.¹⁸,Gagniere C.¹,Vuitton L.¹⁹,Viennot S.²⁰,Aubourg A.²¹,Pelletier A.-L.²²,Bouguen G.²³,Abitbol V.²⁴,Fumery M.²⁵,Claudepierre P.¹,Bouhnik Y.⁸,Amiot A.¹^ORCID,

Affiliation:

1. Creteil France

2. Nancy France

3. Marseille France

4. Nice France

5. Lille France

6. Saint-Etienne France

7. Clermont-Ferrand France

8. Clichy France

9. Nantes France

10. Montpellier France

11. Lariboisière hospital; Paris France

12. Kremlin Bicêtre France

13. Saint-Antoine hospital; Paris France

14. Lyon France

15. Bordeaux France

16. Saint Louis hospital; Paris France

17. Rouen France

18. Toulouse France

19. Besançon France

20. Caen France

21. Tours France

22. Bichat hospital; Paris France

23. Rennes France

24. Cochin Hospital; Paris France

25. Amiens France

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.14419/fullpdf

Reference52 articles.

1. The natural history of adult Crohn's disease in population-based cohorts;Peyrin-Biroulet;Am J Gastroenterol,2010

2. The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease;Harbord;J Crohns Colitis,2016

3. The prevalence of inflammatory sacroiliitis assessed on magnetic resonance imaging of inflammatory bowel disease: a retrospective study performed on 186 patients;Leclerc-Jacob;Aliment Pharmacol Ther,2014

4. Review article: non-malignant oral manifestations in inflammatory bowel diseases;Katsanos;Aliment Pharmacol Ther,2015

5. Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease;Fiorino;Expert Rev Clin Immunol,2010

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of Paradoxical Rheumatoid Arthritis in Inflammatory Bowel Disease Patients Exposed to Tumor Necrosis Factor Inhibitors: A Propensity-Matched Multicenter Study;Inflammatory Bowel Diseases;2024-09-11

2. Is JAK inhibitor the option to prevent difficult‐to‐manage axial spondyloarthritis?;International Journal of Rheumatic Diseases;2024-09

3. Personalised therapy in inflammatory bowel disease;Gastroenterología y Hepatología (English Edition);2024-08

4. Biologics in Focus: A Comprehensive Review of Current Biological and Small Molecules Therapies for Crohn’s Disease in the United Arab Emirates (UAE);Gastrointestinal Disorders;2024-07-07

5. Initiation of vedolizumab did not provoke new‐onset spondylarthritis in patients with inflammatory bowel disease: A prospective 24‐week study with imaging assessments;United European Gastroenterology Journal;2024-07-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3